NAD Finds Certain Claims for Kendamil Infant Formulas Supported; Recommends Others be Modified or Discontinued
NAD recommended Kendal discontinue the “FDA Approved” claim on product packaging to avoid conveying the misleading message that Kendamil’s formula is endorsed or formally approved by the FDA.










